Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
06/2003
06/11/2003EP1317480A2 Rabbit hemorrhagic disease vaccine and antigens
06/11/2003CN1422950A Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
06/10/2003US6576456 Chimeric adenovirus fiber protein
06/10/2003US6576234 Reovirus for the treatment of neoplasia
06/10/2003CA2234208C Influenza vaccine
06/10/2003CA2166367C Live recombinant avian vaccine using an avian herpesvirus as vector
06/05/2003WO2003046506A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
06/05/2003WO2003046190A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
06/05/2003WO2003046189A1 Flavivirus vaccine delivery system
06/05/2003WO2003046142A2 Methods for producing stocks of recombinant aav virions
06/05/2003WO2003046138A2 Genetically stable expression vector
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2002086072A3 Antimicrobial polypeptides and their uses
06/05/2003US20030106104 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106103 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/05/2003US20030106102 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106101 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030104625 Novel oncolytic adenoviral vectors
06/05/2003US20030104624 Novel vector constructs
06/05/2003US20030104613 Amplification of cell proliferation using polyvinylpyrrolidone as activitor; antiapoptosis; genetically engineered tissue for the propagation of polio, rabies, hepatitis or rubella viruses
06/05/2003US20030104612 Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine
06/05/2003US20030104611 Feline immunodeficiency virus gene therapy vectors
06/05/2003US20030104577 Gag genes and gag protein; cell-free translation; transcriptases; viricides; enzyme inhibitors
06/05/2003US20030104576 Methylation inhibitors; vaccines; viricides
06/05/2003US20030104441 Method of concentrating and recovering a viral enzyme activity from biological samples
06/05/2003US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer
06/05/2003US20030104011 Inactivated reverse transcriptase.
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030103942 Comprises recombinant adeno-associated virus vectors encoding TNF antagonist; antiinflammatory agents for connective tissues and joints
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2454397A1 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315823A2 Methods for stable transduction of cells with viral vectors
06/04/2003EP1315799A2 Attenuated hiv strains and use thereof
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP0848752B1 Method for purifying viruses by chromatography
06/04/2003CN1110564C Adenovirus without viable contaminant particle, preparation and use thereof
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110553C Gene engineering adenovirus and it application
06/03/2003US6573081 Method for growing circoviruses
06/03/2003US6573080 Buffalo green monkey kidney and a first type selected from human mucoepidermoid and lung carcinoma cells; detection of enterovirus
06/03/2003US6573079 Methods and interferon deficient substrates for the propagation of viruses
06/03/2003US6573041 Determining reactivation, induction and suppression of virus latency
06/03/2003US6572863 Genome is modified to disable VPR and TAT to prevent their expression; stop codons to prevent translation
06/03/2003CA2101639C Herpes simplex virus-1 deletion variants and vaccines thereof
05/2003
05/30/2003WO2003044202A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003WO2003044184A1 Treatment of pml targeting jc virus agno
05/30/2003WO2003043654A1 Recombinant vaccinia virus vaccine
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2002086068A3 Methods for producing recombinant coronavirus
05/30/2003WO2002068632A3 Methods to identify mutant cells with altered sialic acid
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2445078A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/29/2003US20030101489 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
05/29/2003US20030101488 Nucleotide sequences coding lyase for use in controlling aging and apoptosis in plants
05/29/2003US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE)
05/29/2003US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
05/29/2003US20030099670 Comprises RNA-sequence encoding modified RNA-polymerase due to wild-type point mutations apy; genetic engineering; immunotherapy
05/29/2003US20030099669 Method of protein production using mitochondrial translation system
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099667 Virus modified by the insertion of cDNA of serotypes
05/29/2003US20030099619 Method and composition for targeting an adenoviral vector
05/29/2003US20030099616 Synergistically targeting the malignant cells, transduction of the vector into a mammalian cell, gene expressing telomerase reverse transcriptase causes killing of the cancer cell; genetic engineering
05/29/2003US20030099615 Porcine adenovirus E1 and E4 regions
05/29/2003US20030099613 An encoded repressor or activator and a viral nucleotide sequence for replication; preparing a vaccine for the prophylaxis of AIDS, human immunodeficiency virus
05/28/2003EP1314738A1 Pseudovirons comprising virus capsids, histones and nucleic acids as therapeutic agents
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1313469A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
05/28/2003EP0592546B1 Immunodeficiency virus recombinant poxvirus vaccine
05/28/2003CN1420923A Infection of eukaryotic cells with viruses in vitro
05/28/2003CN1420721A Formulation of preservation mixtures conty. sensitive biologicals to be stabilized for ambient temp. storage by drying
05/28/2003CN1420169A Multifunctional anticancer recombinant adenovirus and use thereof for treating and preventing tumor
05/28/2003CN1420126A Method for preparing recombinant human plasminogen kringle 5 mutant protein rhpk-5
05/28/2003CN1109754C Generation of allfunctional auxiliary virus for producing recombinant adeno-associated virus, and use thereof
05/27/2003US6569679 Recombinant viral vector capable of expressing a gene product that activates a non-cytotoxic compound into a toxic product; use in treatment of viral diseases, cancer, genetic diseases
05/27/2003US6569677 Viral genome mutations involving the recognition and binding of natural cell receptors for adenoviruses; use in human gene therapy applications
05/27/2003US6569426 Tresyl-monomethoxypolyethylene glycol-modified viruses having viral infectivity
05/27/2003US6569422 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
05/27/2003US6569340 Manufacturing universal plasma from blood comprising serological Group A and/or Group B antibodies; contacting with a chromatography resin comprising corresponding Group A and/or Group B antigen
05/27/2003CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
05/22/2003WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003WO2003041830A2 Macroporous gel, its preparation and its use
05/22/2003WO2002090550A3 Method for preparing recombinant poxvirus
05/22/2003WO2002072754A3 Mva expressing modified hiv envelope, gag, and pol genes
05/22/2003WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
05/22/2003WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003US20030096787 Comprising the ITR sequences, a sequence permitting the encapsulation, a heterologous DNA sequence, and in which the E1 gene and at least one of the E2, E4 and L1-L5 genes is non-functional
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096397 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
05/22/2003US20030096259 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs), homogeneous VLP and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents
05/22/2003US20030095989 Chimeric cytolytic viruses for cancer treatment
05/22/2003US20030095987 Recombinant parainfluenza virus expression system and vaccines
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 267